Sensus Healthcare (SRTS) Cash & Equivalents (2015 - 2026)

Sensus Healthcare has reported Cash & Equivalents for 12 years, with the latest figure at $18.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 3.91% year-over-year to $18.3 million; the trailing twelve-month figure through Mar 2026 stood at $18.3 million (down 3.91% YoY), and the FY2025 full-year result was $22.1 million, changed 0.12% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $18.3 million, down from $22.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $37.6 million in Q3 2022, with the low at $14.7 million in Q1 2024.
• Average Cash & Equivalents over 5 years is $23.4 million, with a median of $22.1 million recorded in 2025.
• Year-over-year, Cash & Equivalents jumped 140.48% in 2022 and tumbled 45.48% in 2023.
• Tracing SRTS's Cash & Equivalents over 5 years: stood at $25.5 million in 2022, then fell by 9.29% to $23.1 million in 2023, then slipped by 4.72% to $22.1 million in 2024, then gained by 0.12% to $22.1 million in 2025, then retreated by 17.01% to $18.3 million in 2026.
• The last three Cash & Equivalents figures came in at $18.3 million (Q1 2026), $22.1 million (Q4 2025), and $24.5 million (Q3 2025), per Business Quant data.

Peer Comparison